Computer Peripheral Equipment, NEC · SIC 3577

Ainos, Inc.

AIMD

Watch

Latest revenue

$161

as of 2026-03-31

Latest net income

$-2.5M

as of 2026-03-31

Net margin

-1527826.1%

as of 2026-03-31

Price · 5Y

-66.5% / yr 80.3 pts / yr vs S&P 500 99.6% total
Compare:

Live market

delayed ≤15 min
$1.53
3.16%
Market cap
$13.0M
Enterprise value
$13.0M
P/E (trailing)
Forward P/E
P/B
Dividend yield
0.0%
52-wk high
$4.50
52-wk low
$0.45
Beta
Shares out
8.5M

5-year trend

What this company does

AI

ITEM 1. BUSINESS. Overview Ainos, Inc. (the “Company”), incorporated in the State of Texas in 1984, is a dual-platform company advancing artificial intelligence–based smelltech technologies and immune therapeutics. Our primary strategic focus is the commercialization of our proprietary scent digitization platform, AI Nose, while we also continue to develop therapeutic assets based on our low-dose oral interferon program, VELDONA®. Our core technology platform, AI Nose, is an AI-based electronic olfaction system that integrates gas sensor arrays with proprietary artificial intelligence models, which we refer to as a smell language model (“SLM”), to digitize scent and volatile organic…

AI summary unavailable — showing raw filing excerpt

Generated from AIMD's filing dated 2026-03-30

Key risks

AI

ITEM 1A. RISK FACTORS. Investors should carefully consider the following discussion of significant factors, events, and uncertainties that make an investment in our securities risky. The events and consequences discussed in these risk factors could, in circumstances we may or may not be able to accurately predict, recognize, or control, have a material adverse effect on our business, growth, reputation, prospects, financial condition, operating results (including components of our financial results), cash flows, liquidity, and stock price. These risk factors do not identify all risks that we face; our operations could also be affected by factors, events, or uncertainties that are not…

AI summary unavailable — showing raw filing excerpt

Generated from AIMD's filing dated 2026-03-30

Profitability

Gross margin

82.9%

153.9%

Operating margin

-11268.3%

83.1%

Net margin

-11897.0%

83.4%

Return on equity

-195.3%

103.9%

Return on assets

-70.8%

37.2%

Leverage

Debt / equity

1.76×

105.2%

Long-term debt / equity

1.45×

150.8%

Debt / assets

63.8%

38.1%

Earnings tracker

QuarterRevenueYoYNet incomeYoYNet margin

Q1 2026

2026-03-31

$161-99.8%$-2.5M+25.1%-1527826.1%

Q4 2025

2025-12-31

$11.1K+126.8%$-4.5M+4.0%-40182.5%

Q3 2025

2025-09-30

$2.2K-89.5%$-2.9M+20.8%-135288.5%

Q2 2025

2025-06-30

$4.7K-77.5%$-4.1M-27.9%-87604.3%

Q1 2025

2025-03-31

$106.2K+412.4%$-3.3M+0.9%-3094.0%

Q4 2024

2024-12-31

$-41.5K$-4.7M

Q3 2024

2024-09-30

$20.7K-15.4%$-3.7M-24.3%-17846.1%

Q2 2024

2024-06-30

$20.7K-27.4%$-3.2M-36.0%-15413.3%

Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.

Industry trend

Computer Peripheral Equipment, NEC · SIC 3577

No data yet for industry average

Your notes

Keep private notes on AIMD — thesis, target price, catalysts to watch.

Visible only to you. Never shared. Never used to train AI.

Sign in to write a note

Insider activity

Insider buying

$5.3K

Insider selling

$293.0K

Net activity

−$287.8K

Distinct insiders

5

Open-market trades over the last 365 days.

Recent transactions

DateInsiderTypeSharesPriceValue
2026-05-19

Yao-Chung Chiang

Director

Purchase2,200$1.68$3.7K
2026-05-18

Yao-Chung Chiang

Director

Purchase500$1.65$825
2026-05-05

Yao-Chung Chiang

Director

Purchase129$1.70$219
2026-04-30

Yao-Chung Chiang

Director

Purchase200$1.68$336
2026-04-29

Yao-Chung Chiang

Director

Purchase100$1.75$175
2026-04-12

ASE Test, Inc.

10%+ owner

Purchasederiv.5,994
2026-01-28

Taiwan Carbon Nano Technology Corp

10%+ owner

Sale46,000$2.17$99.8K
2026-01-09

Taiwan Carbon Nano Technology Corp

10%+ owner

Sale431$1.86$802
2026-01-08

Taiwan Carbon Nano Technology Corp

10%+ owner

Sale850$1.80$1.5K
2025-10-06

Taiwan Carbon Nano Technology Corp

10%+ owner

Sale7,000$3.59$25.1K
2025-10-02

Taiwan Carbon Nano Technology Corp

10%+ owner

Sale2,000$3.58$7.2K
2025-10-01

Taiwan Carbon Nano Technology Corp

10%+ owner

Sale1,700$3.46$5.9K
2025-09-30

Taiwan Carbon Nano Technology Corp

10%+ owner

Sale1,006$3.52$3.5K
2025-08-06

Taiwan Carbon Nano Technology Corp

10%+ owner

Sale20,000$2.95$59.0K
2025-08-05

Taiwan Carbon Nano Technology Corp

10%+ owner

Sale11,191$2.44$27.3K
2025-07-18

Taiwan Carbon Nano Technology Corp

10%+ owner

Sale7,000$2.81$19.6K
2025-07-17

Taiwan Carbon Nano Technology Corp

10%+ owner

Sale7,001$2.80$19.6K

Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.

Who owns AIMD

Institutional value

$104.8K

Total shares held

75.4K

Distinct holders

9

-4 vs prior

As of

2026-03-31

Prior: 2025-12-31

Filers with $100M+ AUM disclose holdings 45 days after quarter end.

Top institutional holders

#ManagerSharesValueQoQ changeAction
1Mariner, LLC30.8K$42.8K+8.0K (+35.1%)Added
2Keystone Financial Group14.6K$20.2KNew
3VANGUARD FIDUCIARY TRUST CO14.2K$19.7KNew
4VANGUARD CAPITAL MANAGEMENT LLC9.3K$12.9KNew
5BlackRock, Inc.3.1K$4.3K+0 (+0.0%)No change
6Seneschal Advisors, LLC1.8K$2.5K+0 (+0.0%)No change
7Steward Partners Investment Advisory, LLC1.2K$1.7K+0 (+0.0%)No change
8CITIGROUP INC501$696-313 (-38.5%)Trimmed
9UBS Group AG2$3-583 (-99.7%)Trimmed

Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.

Top questions investors are asking

Coming once AIMD's latest filing finishes processing.